PNC Financial Services Group
ALLO icon

PNC Financial Services Group’s Allogene Therapeutics ALLO Stock Holding History

PNC Financial Services Group’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46K Buy
+3,057
New +$6.13K ﹤0.01% 4084
2025
Q3 		– Sell
-85
Closed -$96 – 5086
2025
Q2 		$96 Sell
85
-257
-75% -$342 ﹤0.01% 4838
2025
Q1 		$499 Buy
342
+154
+82% +$290 ﹤0.01% 4646
2024
Q4 		$400 Buy
188
+10
+6% +$25 ﹤0.01% 4562
2024
Q3 		$498 Sell
178
-2,500
-93% -$6.67K ﹤0.01% 4567
2024
Q2 		$6.24K Hold
2,678
– – ﹤0.01% 3931
2024
Q1 		$12K Hold
2,678
– – ﹤0.01% 3678
2023
Q4 		$8.6K Sell
2,678
-194
-7% -$550 ﹤0.01% 3778
2023
Q3 		$9.1K Buy
2,872
+372
+15% +$1.63K ﹤0.01% 3793
2023
Q2 		$12.4K Sell
2,500
-31
-1% -$168 ﹤0.01% 3778
2023
Q1 		$12.5K Hold
2,531
– – ﹤0.01% 3709
2022
Q4 		$15.9K Hold
2,531
– – ﹤0.01% 3582
2022
Q3 		$27K Hold
2,531
– – ﹤0.01% 3299
2022
Q2 		$29K Sell
2,531
-450
-15% -$4K ﹤0.01% 3295
2022
Q1 		$27K Buy
2,981
+17
+0.6% +$177 ﹤0.01% 3430
2021
Q4 		$44K Buy
2,964
+14
+0.5% +$247 ﹤0.01% 3173
2021
Q3 		$76K Sell
2,950
-19
-0.6% -$451 ﹤0.01% 2808
2021
Q2 		$77K Buy
2,969
+19
+0.6% +$542 ﹤0.01% 2805
2021
Q1 		$104K Hold
2,950
– – ﹤0.01% 2553
2020
Q4 		$74K Hold
2,950
– – ﹤0.01% 2668
2020
Q3 		$111K Buy
2,950
+450
+18% +$17K ﹤0.01% 2262
2020
Q2 		$107K Buy
+2,500
New +$90.4K ﹤0.01% 2286

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's ALLO Position: Q1 2026 in Review

PNC Financial Services Group opened a new position in Allogene Therapeutics (ALLO) in Q1 2026: 3,057 shares worth $7.46K. The stake represents ﹤0.01% of the portfolio and ranks #4084 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in ALLO as recently as Q2 2025.

PNC Financial Services Group first reported a position in ALLO in Q2 2020 and has held it in 22 quarters since. The position peaked at $111K in Q3 2020. 208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • PNC Financial Services Group held 3,057 shares of Allogene Therapeutics worth $7.46K as of Q1 2026.
  • Allogene Therapeutics was a new PNC Financial Services Group position in Q1 2026.
  • Allogene Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4084 holding.
  • PNC Financial Services Group first reported a position in Allogene Therapeutics in Q2 2020 and has held it in 22 quarters since.
  • PNC Financial Services Group's Allogene Therapeutics position peaked at $111K in Q3 2020.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.